These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
470 related articles for article (PubMed ID: 31086306)
1. The proportion of endometrial cancers associated with Lynch syndrome: a systematic review of the literature and meta-analysis. Ryan NAJ; Glaire MA; Blake D; Cabrera-Dandy M; Evans DG; Crosbie EJ Genet Med; 2019 Oct; 21(10):2167-2180. PubMed ID: 31086306 [TBL] [Abstract][Full Text] [Related]
3. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study. Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419 [TBL] [Abstract][Full Text] [Related]
4. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China. Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry. Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542 [TBL] [Abstract][Full Text] [Related]
6. Comparison of Colorectal and Endometrial Microsatellite Instability Tumor Analysis and Premm Mannucci A; Furniss CS; Ukaegbu C; Horiguchi M; Fehlmann T; Uno H; Yurgelun MB; Syngal S J Clin Oncol; 2020 Dec; 38(34):4086-4094. PubMed ID: 32997573 [TBL] [Abstract][Full Text] [Related]
7. Lynch syndrome identification in a Brazilian cohort of endometrial cancer screened by a universal approach. Rosa RCA; Santis JO; Teixeira LA; Molfetta GA; Dos Santos JTT; Ribeiro VDS; Chahud F; Ribeiro-Silva A; Brunaldi MO; Silva WA; Ferraz VEF Gynecol Oncol; 2020 Oct; 159(1):229-238. PubMed ID: 32694065 [TBL] [Abstract][Full Text] [Related]
8. Comparison of universal screening in major lynch-associated tumors: a systematic review of literature. Kunnackal John G; Das Villgran V; Caufield-Noll C; Giardiello FM Fam Cancer; 2022 Jan; 21(1):57-67. PubMed ID: 33426601 [TBL] [Abstract][Full Text] [Related]
9. Mismatch-repair deficiency, microsatellite instability, and lynch syndrome in ovarian cancer: A systematic review and meta-analysis. Mitric C; Salman L; Abrahamyan L; Kim SR; Pechlivanoglou P; Chan KKW; Gien LT; Ferguson SE Gynecol Oncol; 2023 Mar; 170():133-142. PubMed ID: 36682091 [TBL] [Abstract][Full Text] [Related]
10. Performance of tumor testing for Lynch syndrome identification in patients with colorectal cancer: A retrospective single-center study. Signoroni S; Tibiletti MG; Ricci MT; Milione M; Perrone F; Pensotti V; Chiaravalli AM; Carnevali I; Morabito A; Bertario L; Vitellaro M Tumori; 2019 Feb; 105(1):76-83. PubMed ID: 30117378 [TBL] [Abstract][Full Text] [Related]
11. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome. Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759 [TBL] [Abstract][Full Text] [Related]
12. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing. Ferguson SE; Aronson M; Pollett A; Eiriksson LR; Oza AM; Gallinger S; Lerner-Ellis J; Alvandi Z; Bernardini MQ; MacKay HJ; Mojtahedi G; Tone AA; Massey C; Clarke BA Cancer; 2014 Dec; 120(24):3932-9. PubMed ID: 25081409 [TBL] [Abstract][Full Text] [Related]
13. PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinomas, Including Lynch Syndrome-associated and MLH1 Promoter Hypermethylated Tumors. Sloan EA; Ring KL; Willis BC; Modesitt SC; Mills AM Am J Surg Pathol; 2017 Mar; 41(3):326-333. PubMed ID: 27984238 [TBL] [Abstract][Full Text] [Related]
14. An Analysis of Clinical, Surgical, Pathological and Molecular Characteristics of Endometrial Cancer According to Mismatch Repair Status. A Multidisciplinary Approach. Dondi G; Coluccelli S; De Leo A; Ferrari S; Gruppioni E; Bovicelli A; Godino L; Coadă CA; Morganti AG; Giordano A; Santini D; Ceccarelli C; Turchetti D; De Iaco P; Perrone AM Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003368 [TBL] [Abstract][Full Text] [Related]
15. Highly Sensitive Microsatellite Instability and Immunohistochemistry Assessment in Endometrial Aspirates as a Tool for Cancer Risk Individualization in Lynch Syndrome. Canet-Hermida J; Marín F; Dorca E; Dueñas N; Costas L; Salinas M; Velasco À; Peremiquel-Trillas P; Paytubi S; Ponce J; Fernández S; Martínez JM; Cárdenas L; Taltavull A; Alemany L; Meléndez C; Oliveras G; Vidal A; Capellá G; López-Bonet E; Brunet J; Matias-Guiu X; Pineda M Mod Pathol; 2023 Jul; 36(7):100158. PubMed ID: 36918055 [TBL] [Abstract][Full Text] [Related]
16. Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome. Watkins JC; Yang EJ; Muto MG; Feltmate CM; Berkowitz RS; Horowitz NS; Syngal S; Yurgelun MB; Chittenden A; Hornick JL; Crum CP; Sholl LM; Howitt BE Int J Gynecol Pathol; 2017 Mar; 36(2):115-127. PubMed ID: 27556954 [TBL] [Abstract][Full Text] [Related]
17. Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries. Ryan P; Mulligan AM; Aronson M; Ferguson SE; Bapat B; Semotiuk K; Holter S; Kwon J; Kalloger SE; Gilks CB; Gallinger S; Pollett A; Clarke BA Cancer; 2012 Feb; 118(3):681-8. PubMed ID: 21721000 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer. Post CCB; Stelloo E; Smit VTHBM; Ruano D; Tops CM; Vermij L; Rutten TA; Jürgenliemk-Schulz IM; Lutgens LCHW; Jobsen JJ; Nout RA; Crosbie EJ; Powell ME; Mileshkin L; Leary A; Bessette P; Putter H; de Boer SM; Horeweg N; Nielsen M; Wezel TV; Bosse T; Creutzberg CL J Natl Cancer Inst; 2021 Sep; 113(9):1212-1220. PubMed ID: 33693762 [TBL] [Abstract][Full Text] [Related]
19. Lynch Syndrome Identification in Saudi Cohort of Endometrial Cancer Patients Screened by Universal Approach. Bu R; Siraj AK; Parvathareddy SK; Iqbal K; Azam S; Qadri Z; Al-Rasheed M; Haqawi W; Diaz M; Alobaisi K; Annaiyappanaidu P; Siraj N; AlHusaini H; Alomar O; Al-Badawi IA; Al-Dayel F; Al-Kuraya KS Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293153 [TBL] [Abstract][Full Text] [Related]
20. Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities. Garg K; Leitao MM; Kauff ND; Hansen J; Kosarin K; Shia J; Soslow RA Am J Surg Pathol; 2009 Jun; 33(6):925-33. PubMed ID: 19238076 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]